➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Harvard Business School
McKesson
Johnson and Johnson
Medtronic

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NOVOSEVEN

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for NOVOSEVEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00104455 Dose Response to Recombinant Factor VIIa When Administered for Bleed Completed Novo Nordisk A/S Phase 1 2004-06-01 This trial is conducted in the United States of America (USA). The purpose of this trial is to investigate the dose response to recombinant factor VIIa in healthy volunteers when administered for bleed.
NCT00108758 Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia Completed Novo Nordisk A/S Phase 2 2004-03-01 This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylactic treatment with NovoSeven® in haemophilia A and B patients with inhibitors.
NCT00108797 Trial of NovoSeven® in Haemophilia - Joint Bleeds Completed Novo Nordisk A/S Phase 4 2001-09-01 This trial is conducted in the United States of America (USA). This study compares the effectiveness and safety of NovoSeven® to FEIBA (FEIBA VH) in haemophilia patients with inhibitors being treated for joint bleeds.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NOVOSEVEN

Condition Name

Condition Name for NOVOSEVEN
Intervention Trials
Congenital Bleeding Disorder 23
Acquired Bleeding Disorder 20
Haemophilia B With Inhibitors 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NOVOSEVEN
Intervention Trials
Blood Coagulation Disorders 41
Hemostatic Disorders 41
Hemophilia A 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NOVOSEVEN

Trials by Country

Trials by Country for NOVOSEVEN
Location Trials
United States 122
Germany 18
United Kingdom 16
Italy 16
France 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NOVOSEVEN
Location Trials
California 9
New Jersey 8
Texas 8
Pennsylvania 7
Ohio 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NOVOSEVEN

Clinical Trial Phase

Clinical Trial Phase for NOVOSEVEN
Clinical Trial Phase Trials
Phase 4 4
Phase 3 7
Phase 2 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NOVOSEVEN
Clinical Trial Phase Trials
Completed 43
Terminated 4
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NOVOSEVEN

Sponsor Name

Sponsor Name for NOVOSEVEN
Sponsor Trials
Novo Nordisk A/S 43
National Institute of Neurological Disorders and Stroke (NINDS) 2
Octapharma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NOVOSEVEN
Sponsor Trials
Industry 44
Other 12
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Boehringer Ingelheim
Medtronic
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.